InjectionCritical Care Injection Infusion

REMDESIVIR

Remdesivir · Nucleotide analogue antiviral

InjectionCritical Care Injection Infusion

REMDESIVIRProspero Healthcare

Remdesivir is a nucleotide analogue antiviral that inhibits viral RNA polymerase, given by intravenous infusion. It is used in the treatment of COVID-19 in suitable patients under medical supervision.

Uses

COVID-19 in hospitalised patients

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Remdesivir
Available strengthsIndicative: 100 mg/vial
Dosage form: Injection
Therapeutic category: Critical Care Injection Infusion
Therapeutic class: Nucleotide analogue antiviral
Packing: Vial or ampoule, single unit or tray pack
Storage: Store below 25 °C, protected from light. Do not freeze.

02Related

From the same category

View the category

Injection
PIRACETAM INJECTION
PIRACETAM INJECTIONInjection
Injection
UROKINASE
UROKINASEInjection
Injection
Bortezomib Injection
Bortezomib InjectionInjection
Injection
DOBUTAMINE HCI
DOBUTAMINE HCIInjection
Injection
Iohexol Injection
Iohexol InjectionInjection
Injection
MICONAZOLE
MICONAZOLEInjection